Converting a tumor from checkpoint blockade-resistant to checkpoint blockade-sensitive: Immunotransplant for aggressive lymphoma.
2016
e14538Background: Lymphomas comprise the 5thmost common cancers in the U.S. and the majority of these are incurable with standard chemo-immunotherapy, thus, novel, mechanistically distinct therapie...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI